TCL Archive Congress Passes Unprecedented 15% Increase For NIH On Last Day Of Session October 23, 1998
TCL Archive FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug July 26, 2013
TCL Archive FASEB Seeks $27.3B For NIH, Increases For Research, Training, And Infrastructure. February 1, 2002
TCL Archive Conversation with The Cancer Letter: Kazerooni: The Case for Broad Coverage March 21, 2014
